CYP17A1 Polymorphisms Are Linked to the Risk of Coronary Heart Disease in a Case–Control Study. Issue 2 (August 2019)

• Record Type: Journal Article
• Authors: Lu, Shijuan; Zhong, Jianghua; Zhang, Yingai; Huang, Kang; Wu, Miao; Zhou, Yilei; Li, Qiang; Chen, Zibin; Zhang, Shufang; Zhou, Honghao
• Is Part Of: Journal of cardiovascular pharmacology. Volume 74:Issue 2(2019)
• Publication Date: 2019-08
• Subjects: coronary heart disease -- CYP17A1 -- polymorphism -- case–control study; Cardiovascular Diseases -- drug therapy -- Periodicals; Cardiovascular System -- drug effects -- Periodicals; Cardiovascular pharmacology -- Periodicals; Cardiovascular agents -- Periodicals; Cardiovascular agents; Cardiovascular pharmacology; Periodicals; 615.7105
• DOI: 10.1097/FJC.0000000000000687
• Languages: English
• ISSNs: 0160-2446

Abstract

Abstract : Background: Cytochrome P450 17A1 ( CYP17A1 ) catalyzes the formation and metabolism of steroid hormones and is required for cortisol and androgens. There is increasing evidence that CYP17A1 plays an important role in the development of coronary heart disease (CHD). However, the association of CYP17A1 polymorphisms and CHD susceptibility is still not clear. Methods: We conducted a case–control study with 396 CHD cases and 461 healthy controls from Hainan province, China. Using the Agena MassARRAY platform, we genotyped 4 genetic variants (rs3740397, rs1004467, rs4919687, and rs3781286) in CYP17A1 . Logistic regression analysis was used to assess the association of CYP17A1 polymorphisms with CHD risk by odds ratios (ORs) and 95% confidence intervals (CIs). Results: It showed that A allele of CYP17A1 rs4919687 carried with a 1.59-fold increased risk of CHD (OR = 1.59; 95% CI = 1.26–1.99; P < 0.001). Also, rs4919687 was significantly associated with CHD risk under various models (homozygote: OR = 3.60; 95% CI = 1.64–7.83; P = 0.001; dominant: OR = 1.51; 95% CI = 1.06–2.13; P = 0.021; recessive: OR = 3.28; 95% CI = 1.51–7.14; P = 0.003; additive: OR = 1.56; 95% CI = 1.17–2.07; P = 0.002). Moreover, analysis showed that Ars1004467 Ars4919687 haplotype was a protective factor of CHD (OR = 0.64; 95% CI = 0.48–0.86; P = 0.002). Conclusions: Our study suggests that CYP17A1 polymorphisms are associated with CHD susceptibility in the Hainan Han Chinese population.